Digital Look

Welcome to Digital Look++,
you are not logged in

AstraZeneca (AZNL)

14,088.00p

Select chart: EPS | Revenue

Period Ending	Period	Revenue ($m)	Pre-tax ($m)	EPS	Dividend
30-Sep-25	Q3	15,191.00	3,244.00	164.00¢	n/a

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	26,617.00	3,916.00	244.00¢	40.6	0.3	+137%	280.00¢	2.8%
31-Dec-21	37,417.00	(265.00)	8.00¢	1,460.1	n/a	-97%	287.00¢	2.5%
31-Dec-22	44,351.00	2,501.00	212.00¢	71.5	0.0	+2,550%	290.00¢	1.9%
31-Dec-23	45,811.00	6,899.00	726.00¢	19.7	0.1	+242%	290.00¢	2.0%
31-Dec-24	54,073.00	8,691.00	821.00¢	17.2	1.3	+13%	310.00¢	2.2%

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-25	58,657.54	18,445.79	679.83p	20.7	1.8	+11%	240.45p	0.0%
31-Dec-26	62,230.27	20,654.95	764.97p	18.4	1.5	+12%	253.12p	0.0%
31-Dec-27	65,863.12	22,840.52	853.64p	16.5	1.4	+12%	263.76p	0.0%

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	41.10	15.94	320.56	0.07

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.